These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27842887)

  • 41. Non-targeted metabolomics-guided sildenafil metabolism study in human liver microsomes.
    Kim JH; Jo JH; Seo KA; Hwang H; Lee HS; Lee S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():86-93. PubMed ID: 29136555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of peak-picking workflows for untargeted liquid chromatography/high-resolution mass spectrometry metabolomics data analysis.
    Rafiei A; Sleno L
    Rapid Commun Mass Spectrom; 2015 Jan; 29(1):119-27. PubMed ID: 25462372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolomics for bioactivity assessment of natural products.
    Yuliana ND; Khatib A; Choi YH; Verpoorte R
    Phytother Res; 2011 Feb; 25(2):157-69. PubMed ID: 20658470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sample preparation prior to the LC-MS-based metabolomics/metabonomics of blood-derived samples.
    Gika H; Theodoridis G
    Bioanalysis; 2011 Jul; 3(14):1647-61. PubMed ID: 21756097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ion identity molecular networking for mass spectrometry-based metabolomics in the GNPS environment.
    Schmid R; Petras D; Nothias LF; Wang M; Aron AT; Jagels A; Tsugawa H; Rainer J; Garcia-Aloy M; Dührkop K; Korf A; Pluskal T; Kameník Z; Jarmusch AK; Caraballo-Rodríguez AM; Weldon KC; Nothias-Esposito M; Aksenov AA; Bauermeister A; Albarracin Orio A; Grundmann CO; Vargas F; Koester I; Gauglitz JM; Gentry EC; Hövelmann Y; Kalinina SA; Pendergraft MA; Panitchpakdi M; Tehan R; Le Gouellec A; Aleti G; Mannochio Russo H; Arndt B; Hübner F; Hayen H; Zhi H; Raffatellu M; Prather KA; Aluwihare LI; Böcker S; McPhail KL; Humpf HU; Karst U; Dorrestein PC
    Nat Commun; 2021 Jun; 12(1):3832. PubMed ID: 34158495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Applications of mass spectrometry in drug metabolism: 50 years of progress.
    Wen B; Zhu M
    Drug Metab Rev; 2015 Feb; 47(1):71-87. PubMed ID: 25639893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted metabolomics for biomarker discovery.
    Griffiths WJ; Koal T; Wang Y; Kohl M; Enot DP; Deigner HP
    Angew Chem Int Ed Engl; 2010 Jul; 49(32):5426-45. PubMed ID: 20629054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies.
    Liu ZY
    J Mass Spectrom; 2012 Dec; 47(12):1627-42. PubMed ID: 23280752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Highly sensitive LC-MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human.
    Grangeon A; Gravel S; Gaudette F; Turgeon J; Michaud V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():144-158. PubMed ID: 27978469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MolDiscovery: learning mass spectrometry fragmentation of small molecules.
    Cao L; Guler M; Tagirdzhanov A; Lee YY; Gurevich A; Mohimani H
    Nat Commun; 2021 Jun; 12(1):3718. PubMed ID: 34140479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma metabolome analysis by integrated ionization rapid-resolution liquid chromatography/tandem mass spectrometry.
    Tian H; Bai J; An Z; Chen Y; Zhang R; He J; Bi X; Song Y; Abliz Z
    Rapid Commun Mass Spectrom; 2013 Sep; 27(18):2071-80. PubMed ID: 23943328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies.
    Plumb RS; Potts WB; Rainville PD; Alden PG; Shave DH; Baynham G; Mazzeo JR
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2139-52. PubMed ID: 18543375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LC-MS-based metabolomics.
    Bajad S; Shulaev V
    Methods Mol Biol; 2011; 708():213-28. PubMed ID: 21207293
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the performance of a tandem mass spectral library with mass spectral data extracted from literature.
    Würtinger P; Oberacher H
    Drug Test Anal; 2012; 4(3-4):235-41. PubMed ID: 21964810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacometabolomics in Early-Phase Clinical Development.
    Burt T; Nandal S
    Clin Transl Sci; 2016 Jun; 9(3):128-38. PubMed ID: 27127917
    [No Abstract]   [Full Text] [Related]  

  • 56. Applied metabolomics in drug discovery.
    Cuperlovic-Culf M; Culf AS
    Expert Opin Drug Discov; 2016 Aug; 11(8):759-70. PubMed ID: 27366968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Towards analytically useful two-dimensional Fourier transform ion cyclotron resonance mass spectrometry.
    van Agthoven MA; Delsuc MA; Bodenhausen G; Rolando C
    Anal Bioanal Chem; 2013 Jan; 405(1):51-61. PubMed ID: 23076397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolomics technology and bioinformatics for precision medicine.
    Azad RK; Shulaev V
    Brief Bioinform; 2019 Nov; 20(6):1957-1971. PubMed ID: 29304189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving natural products identification through targeted LC-MS/MS in an untargeted secondary metabolomics workflow.
    Hoffmann T; Krug D; Hüttel S; Müller R
    Anal Chem; 2014 Nov; 86(21):10780-8. PubMed ID: 25280058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of data pre-processing methods for LC-MS/MS-based metabolomics of uterine cervix cancer.
    Chen Y; Xu J; Zhang R; Shen G; Song Y; Sun J; He J; Zhan Q; Abliz Z
    Analyst; 2013 May; 138(9):2669-77. PubMed ID: 23486772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.